POINT Biopharma to Participate in Upcoming Investor Conferences

On February 2, 2023 POINT Biopharma Global Inc. (NASDAQ: PNT) (the "Company" or "POINT"), a company accelerating the discovery, development, and global access to life-changing radiopharmaceuticals, reported management will participate in the following upcoming investor conferences (Press release, Point Biopharma, FEB 2, 2023, View Source [SID1234626736]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Guggenheim 5th Annual Oncology Conference

Format: Fireside Chat and 1×1 Meetings

Location: New York, NY

Date: Wednesday, February 8, 2023

Time: 2:10 pm ET


SVB Securities Global Biopharma Conference

Format: Fireside Chat and 1×1 Meetings

Location: Virtual

Date: Thursday, February 16, 2023

Time: 11:20 am ET


Cowen 43rd Annual Health Care Conference

Format: GI/GU Oncology Panel Discussion and 1×1 Meetings

Location: Boston, MA

Date: Tuesday, March 7, 2023

Time: 12:50pm ET


Oppenheimer 33rd Annual Healthcare Investor Conference

Format: Fireside Chat and 1×1 Meetings

Location: Virtual

Date: Monday, March 13, 2023

Time: 8:40am ET


2023 Bloom Burton & Co. Healthcare Investor Conference

Format: Presentation and 1×1 Meetings

Location: Toronto, ON

Dates: Tuesday, April 25 and Wednesday, April 26, 2023